MHS, Johns Hopkins Bloomberg School of Public Health, 1998
FRACP, Royal Australasian College of Physicians, 1996
MD, University of Sydney, 1989
Dr Visvanathan is a cancer epidemiologist and a medical oncologist who conducts epidemiological research focused on reducing breast and ovarian cancer incidence and mortality.
Her primary research is focused on the primary and secondary prevention of breast and ovarian cancer through the identification of at risk groups, early detection strategies and the use of preventive agents. Specific areas of interest include: 1) biomarkers for of inflammation, immune status, DNA alterations, obesity, methylation and vitamin D for risk stratification, 2) biomarkers of disease progression (i.e precursor lesions, methylation etc), and 3) evaluation of risk reduction strategies (i.e oophorectomy, hormonal prevention, sulforaphane, statins, beta-blockers, aspirin, and NSAID.
Honors and Awards
1999 AACR-Glaxo Welcome Oncology Scholar Award for Clinical/Translational Research
2001 First Prize in Clinical section John’s Hopkins Fellow Research Day 2004 -2005
2005 ASCO Career Development Award 2005
2012, 2014 Teaching Excellence Award among faculty at JHSPH for Cancer Methods Course
2017 Inducted into Delta Omega Honorary society for public health